Europe Device Reg Reform Proposal: More Scrutiny Of Notified Bodies Expected
This article was originally published in The Gray Sheet
Executive Summary
Industry expects the European Commission to propose more oversight of notified-body reviews by member countries. But the Commission appears to have resisted calls to establish a direct government approval process for devices.
You may also be interested in...
In Europe, Contrarian VC Wellington Partners Favors Medical Devices
In September, Wellington Partners announced that it closed on €70 million ($91 million) in new venture capital, the first commitment for a fund devoted to life science investing. The target size of Wellington Partners IV Life Science Fund is €120 million, a significant increase over its previous fund devoted to the life sciences, which raised €78 million. Five years ago, this event wouldn’t even have been news, but in a world where venture capital funds are generally contracting, and specifically with regard to life sciences, Wellington offers medical device start-ups a bright spot of hope.
EU Device Reform Proposal Adds More Government Scrutiny, But No FDA-Like Review Body
The recommendation attracting the most concern from industry: a new Medical Device Coordination Group that would have the option to scrutinize third-party pre-market assessment reports for select devices prior to marketing.
International News In Brief
In wake of PIP breast implant scandal, a European Parliament committee calls for stronger device laws. More international regulatory news.